To Determine Bioequivalence Under Fasting Conditions Clinical Trial
Official title:
Randomized, Open-Label, 2-Way Crossover, Comparative Bioavailability Study of Par's and Oclassen's (Monodox) Doxycycline Monohydrate Capsules Administered as 1 x 100 mg Capsule in Healthy Adult Males Under Fasting Conditions
To compare the rate and extent of absorption of doxycycline monohydrate capsules equivalent to 100 mg doxycycline (Par) versus Monodox (Oclassen Pharmaceuticals).
To compare the rate and extent of absorption of doxycycline monohydrate capsules equivalent to 100 mg of doxycycline by Par Pharmaceutical, Inc., USA (test) versus Monodox by Oclassen Pharmaceuticals, Inc., USA reference administered as a 1 x 100 mg capsule under fasting conditions. ;
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Crossover Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00653120 -
Bioavailability Study of Propranolol Under Fasting Conditions
|
Phase 2 | |
Completed |
NCT00653315 -
Bioavailability Study of Tramadol/APAP Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00652912 -
Bioavailability Study of Clonazepam ODT Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653419 -
Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00652795 -
Bioequivalence Study Doxycycline Tablets and Monodox Capsules Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT01380457 -
Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT01380483 -
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00652639 -
Bioavailability Study of Clonazepam Tablets Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653055 -
Bioequivalence Study of Cabergoline Tablets and Dostinex Under Fasting Conditions
|
Phase 1 | |
Completed |
NCT00653549 -
Bioavailability Study of Torsemide Tablets Under Fasting Conditions
|
Phase 1 |